These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9451520)

  • 1. Obesity and haemostasis.
    Winkler UH
    Arch Gynecol Obstet; 1997; 261(1):25-9. PubMed ID: 9451520
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity, haemostasis and the fibrinolytic system.
    Mertens I; Van Gaal LF
    Obes Rev; 2002 May; 3(2):85-101. PubMed ID: 12120424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease.
    Pearson TA; LaCava J; Weil HF
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1674S-1682S. PubMed ID: 9129509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 and haemostasis in obesity.
    Mutch NJ; Wilson HM; Booth NA
    Proc Nutr Soc; 2001 Aug; 60(3):341-7. PubMed ID: 11681808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between obesity and a prothrombotic state: the Framingham Offspring Study.
    Rosito GA; D'Agostino RB; Massaro J; Lipinska I; Mittleman MA; Sutherland P; Wilson PW; Levy D; Muller JE; Tofler GH
    Thromb Haemost; 2004 Apr; 91(4):683-9. PubMed ID: 15045128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease.
    Potze W; Siddiqui MS; Sanyal AJ
    Semin Thromb Hemost; 2015 Jul; 41(5):488-93. PubMed ID: 26049073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
    Kelleher CC
    Eur J Epidemiol; 1992 May; 8 Suppl 1():79-82. PubMed ID: 1505657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity.
    Primrose JN; Davies JA; Prentice CR; Hughes R; Johnston D
    Thromb Haemost; 1992 Oct; 68(4):396-9. PubMed ID: 1448769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime study.
    Scarabin PY; Aillaud MF; Luc G; Lacroix B; Mennen L; Amouyel P; Evans A; Ferrières J; Arveiler D; Juhan-Vague I;
    Thromb Res; 2001 May; 102(4):285-93. PubMed ID: 11369422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.
    Braunstein JB; Kershner DW; Bray P; Gerstenblith G; Schulman SP; Post WS; Blumenthal RS
    Chest; 2002 Mar; 121(3):906-20. PubMed ID: 11888977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic function in young subjects with central obesity: relationship with left ventricular function.
    Licata G; Scaglione R; Avellone G; Ganguzza A; Corrao S; Arnone S; Di Chiara T
    Metabolism; 1995 Nov; 44(11):1417-21. PubMed ID: 7476328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic risk factors of coronary artery disease in the Chinese.
    Ho CH; Wang SP; Jap TS
    Int J Cardiol; 1995 Aug; 51(1):79-84. PubMed ID: 8522401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral fat as a determinant of fibrinolysis and hemostasis.
    Mertens I; Van Gaal LF
    Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VII and haemostasis.
    Osterud B
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):175-81. PubMed ID: 2130929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic gene expression and vascular disease in obesity: insights from studies of genetically obese mice.
    Samad F; Loskutoff DJ
    Thromb Haemost; 1999 Aug; 82(2):742-7. PubMed ID: 10605777
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of DEXA-assessed total body fat mass with serum lipids and haemostatic variables.
    De Lorenzo F; Mukherjee M; Kadziola Z; Kakkar VV
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):291-2. PubMed ID: 9663715
    [No Abstract]   [Full Text] [Related]  

  • 18. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivotal role of plasminogen-activator inhibitor 1 in vascular disease.
    Agirbasli M
    Int J Clin Pract; 2005 Jan; 59(1):102-6. PubMed ID: 15707473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.